Mylan Specialty, LP: Clinical Trials

5 trials sponsored by Mylan Specialty, LP, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 2 Phase 2, 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 32Completed 2
Not applicable1Completed 1

Follow Mylan Specialty, LP: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy
MR-107A-02, Tramadol, Placebo - Acute Pain, Post Operative Pain
Phase 3CompletedViatris Specialty LLC5792023-12-292026-02-10
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy
MR-107A-02, Tramadol, Placebo - Acute Pain, Post Operative Pain
Phase 3CompletedViatris Specialty LLC4102023-12-292025-10-14
Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
MR-107A-02, Placebo - Acute Pain, Post Operative Pain
Phase 2CompletedMylan Specialty, LP1112022-03-312023-08-07
COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers
Formoterol, Placebo - COPD Exacerbation
Not applicableCompletedUniversity of Tennessee Graduate School of Medicine72015-02-012019-03-19
Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning
Silibinin - Amatoxin Poisoning, Amanita Poisoning
Phase 2TerminatedMylan Specialty, LP1482009-11-102022-04-07

Conditions studied

Acute Pain (3)  ·  Pain (3)  ·  Pain, Postoperative (3)  ·  Liver Failure (1)  ·  Mushroom Poisoning (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Interventions

Tramadol (2)  ·  Formoterol Fumarate (1)  ·  Herniorrhaphy (1)  ·  Saline Solution (1)  ·  Silybin (1)

Countries

United States (5)

Top investigators

Susanne Vogt (2)  ·  Rajiv Dhand, MD (1)  ·  Wallis Marsh, MD (1)

Results publications

PMID 42509420